PMID- 18776126 OWN - NLM STAT- MEDLINE DCOM- 20090106 LR - 20220410 IS - 1533-3450 (Electronic) IS - 1046-6673 (Print) IS - 1046-6673 (Linking) VI - 19 IP - 12 DP - 2008 Dec TI - Toll-like receptor 9 affects severity of IgA nephropathy. PG - 2384-95 LID - 10.1681/ASN.2007121311 [doi] AB - Environmental pathogens are suspected to aggravate renal injury in IgA nephropathy (IgAN), but neither underlying mechanisms nor specific exogenous antigens have been identified. In this study, a genome-wide scan of ddY mice, which spontaneously develop IgAN, was performed, and myeloid differentiation factor 88 (MyD88) was identified as a candidate gene for progression of renal injury (chi(2) = 21.103, P = 0.00017). For evaluation of the potential influence of environmental pathogens on progression of renal injury, ddY mice were housed in either conventional or specific pathogen-free conditions. Expression of genes encoding toll-like receptors (TLR) and the signaling molecule MyD88 were quantified by real-time reverse transcription-PCR in splenocytes. Although the housing conditions did not affect the prevalence of IgAN, the severity of renal injuries was higher in the conventionally housed group. Mice that had IgAN and were housed in conventional conditions had higher levels of TLR9 and MyD88 transcripts than mice that had IgAN and were housed in specific pathogen-free conditions. Furthermore, nasal challenge with CpG-oligodeoxynucleotides, which are ligands for TLR9, aggravated renal injury, led to strong Th1 polarization, and increased serum and mesangial IgA. For investigation of whether these results may be generalizable to humans, single-nucleotide polymorphisms in the TLR9 and MyD88 genes were analyzed in two cohorts of patients with IgAN; an association was observed between TLR9 polymorphisms and disease progression. In summary, these findings suggest that activation of the TLR9/MyD88 pathway by common antigens may affect the severity of IgAN. FAU - Suzuki, Hitoshi AU - Suzuki H AD - Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan. FAU - Suzuki, Yusuke AU - Suzuki Y FAU - Narita, Ichiei AU - Narita I FAU - Aizawa, Masashi AU - Aizawa M FAU - Kihara, Masao AU - Kihara M FAU - Yamanaka, Takahiro AU - Yamanaka T FAU - Kanou, Tatsuya AU - Kanou T FAU - Tsukaguchi, Hiroyasu AU - Tsukaguchi H FAU - Novak, Jan AU - Novak J FAU - Horikoshi, Satoshi AU - Horikoshi S FAU - Tomino, Yasuhiko AU - Tomino Y LA - eng GR - DK080301/DK/NIDDK NIH HHS/United States GR - DK064400/DK/NIDDK NIH HHS/United States GR - R01 DK078244/DK/NIDDK NIH HHS/United States GR - DK078244/DK/NIDDK NIH HHS/United States GR - R56 DK078244/DK/NIDDK NIH HHS/United States GR - R24 DK064400/DK/NIDDK NIH HHS/United States GR - R21 DK080301/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20080905 PL - United States TA - J Am Soc Nephrol JT - Journal of the American Society of Nephrology : JASN JID - 9013836 RN - 0 (MYD88 protein, human) RN - 0 (Myd88 protein, mouse) RN - 0 (Myeloid Differentiation Factor 88) RN - 0 (TLR9 protein, human) RN - 0 (Tlr9 protein, mouse) RN - 0 (Toll-Like Receptor 9) SB - IM MH - Animals MH - CpG Islands MH - Disease Progression MH - Genetic Predisposition to Disease MH - Glomerulonephritis, IGA/*genetics/*metabolism MH - Humans MH - Japan MH - Mice MH - Models, Biological MH - Myeloid Differentiation Factor 88/*metabolism MH - Polymorphism, Genetic MH - Spleen/cytology/microbiology MH - Toll-Like Receptor 9/*metabolism PMC - PMC2588104 EDAT- 2008/09/09 09:00 MHDA- 2009/01/07 09:00 PMCR- 2009/12/01 CRDT- 2008/09/09 09:00 PHST- 2008/09/09 09:00 [pubmed] PHST- 2009/01/07 09:00 [medline] PHST- 2008/09/09 09:00 [entrez] PHST- 2009/12/01 00:00 [pmc-release] AID - ASN.2007121311 [pii] AID - 1311 [pii] AID - 10.1681/ASN.2007121311 [doi] PST - ppublish SO - J Am Soc Nephrol. 2008 Dec;19(12):2384-95. doi: 10.1681/ASN.2007121311. Epub 2008 Sep 5.